Provided by Tiger Trade Technology Pte. Ltd.

Alpha Tau Medical

14.29
-0.1500-1.04%
Volume:306.33K
Turnover:4.35M
Market Cap:1.32B
PE:-13.59
High:14.62
Open:14.49
Low:14.01
Close:14.44
52wk High:15.17
52wk Low:3.43
Shares:92.33M
Float Shares:63.79M
Volume Ratio:0.63
T/O Rate:0.48%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0517
EPS(LYR):-0.5300
ROE:-141.68%
ROA:-25.71%
PB:29.95
PE(LYR):-26.96

Loading ...

Alpha Tau Medical - Tolmar Granted Exclusive U.S. Rights for Prostate Cancer, Option for Bladder Cancer

THOMSON REUTERS
·
Jun 03

Alpha Tau Medical - Tolmar to Invest $15M in Manufacturing, $20M Equity at $11.99/Share, up to $161.5M in Milestones

THOMSON REUTERS
·
Jun 03

Alpha Tau Medical - to Manufacture Alpha Dart for Tolmar at 60% of Net Sales Price

THOMSON REUTERS
·
Jun 03

Alpha Tau Medical - up to $96.5M in Development and $65M in Commercial Milestone Payments Agreed

THOMSON REUTERS
·
Jun 03

Alpha Tau Medical Price Target Maintained With a $15.00/Share by HC Wainwright & Co.

Dow Jones
·
Jun 03

Alpha Tau Medical Reports Data Showing Alpha DaRT Increases Overall Survival for Patients With Pancreatic Cancer

MT Newswires Live
·
Jun 01

Alpha Tau reports 11.2-month median survival in pooled Phase I/II Alpha DaRT pancreatic cancer studies at ASCO 2026

Reuters
·
Jun 01

Alpha Tau Announces Strong Overall Survival Results From Alpha Dart® Pancreatic Cancer Studies Presented at 2026 Asco Annual Meeting

THOMSON REUTERS
·
Jun 01

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Jun 01

Alpha Tau Medical Initiated at Overweight by Barclays

Dow Jones
·
May 28

Barclays Initiates Alpha Tau Medical With Overweight Rating, $15 Price Target

MT Newswires Live
·
May 28

Alpha Tau :  Barclays Initiates Coverage With Overweight Rating and Target Price $15

THOMSON REUTERS
·
May 28

Barclays Initiates a Buy Rating on Alpha Tau Medical Ltd (DRTS)

TIPRANKS
·
May 28

Analysts Offer Insights on Healthcare Companies: Alpha Tau Medical Ltd (DRTS), Neurogene (NGNE) and Milestone Pharmaceuticals (MIST)

TIPRANKS
·
May 27

Alpha Tau Medical Is Maintained at Neutral by Piper Sandler

Dow Jones
·
May 19

Alpha Tau price target raised to $8 from $5 at Piper Sandler

TIPRANKS
·
May 19

Alpha Tau Medical Sets June 23, 2026 Shareholder Meeting to Vote on Governance and Executive Pay

TIPRANKS
·
May 19

Alpha Tau Medical announces annual shareholder meeting notice and proxy statement

Reuters
·
May 19

Alpha Tau Medical Posts Strong Q1 2026 Trial Progress and Completes Enrollment in First U.S. Pivotal Study

TIPRANKS
·
May 19

Alpha Tau reports Q1 EPS (12c), consensus (12c)

TIPRANKS
·
May 19